clinical trial · NCT04618913
Anticoagulation in Patients With Venous Thromboembolism and Cancer
Pfizer·—·active not recruiting·n = 1
NeoplasmsEmbolismApixabanRivaroxabanEdoxabanDabigatranVKALMWH
brief summary
This study is a retrospective analysis of observational cohorts using data from prospectively collected administrative/claims data to investigate treatment patterns,healthcare resource utilisation (HCRU), direct and indirect costs (where feasible), and safety and effectiveness outcomes in patients with VTE and active cancer or patients with VTE and history of cancer who initiate anticoagulant treatment with a VKA, LMWH or NOACs.
started
Dec 14, 2020
primary completion
Apr 6, 2026
completion
Apr 6, 2026
last updated
Mar 12, 2026
official title
VICTORIE (VTE In Cancer - Treatment, Outcomes and Resource Use In Europe)
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol